[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Summit Therapeutics Inc. Common Stock (SMMT) Summit Therapeutics shares are up amid reports of a potential $15B licensing deal with AstraZeneca. Ivonescimab data disappoints in Western patients, causing concern. ### About Summit Therapeutics Inc. Common Stock Summit Therapeutics Inc. Common Stock (SMMT) is a biopharmaceutical company. Summit Therapeutics Inc. Common Stock uses the ticker $SMMT for trading. Listed in the [Stocks](/list/stocks) and category. ### Insights [#](/topic/$smmt/insights) - Summit Therapeutics Inc. Common Stock (SMMT) trading volume is up XXXXX% from the previous week. - Summit Therapeutics Inc. Common Stock (SMMT) social dominance is up XXXXX% from the previous week. - Summit Therapeutics Inc. Common Stock (SMMT) sentiment is up XXXXXX% from the previous week. - Summit Therapeutics Inc. Common Stock (SMMT) posts created is up XXXXXX% from the previous week. ### Price: $XX [#](/topic/$smmt/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/close.tsv) The XXXX% price increase appears to be driven by positive market sentiment, hype from top creators, the anticipation of Phase X data, and a potential deal with AstraZeneca, fueled by rumors of a $XX billion partnership and increased social engagement. | 24-Hour | 7-Day | 30-Day | | ------- | ----- | ------ | | -XXXX% | -XXXX% | XXXXX% | **1-Year High**: $XXXXX on 2025-04-24 **1-Year Low**: $XXXXX on 2025-04-08 ### AltRank: XXX [#](/topic/$smmt/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/alt_rank.tsv) Summit Therapeutics Inc. Common Stock (SMMT) is currently AltRank #196 based on combined combined social and market metrics **Daily Average**: XXX **1 Week**: XXX +535 **1 Month**: XXX -XXX **6 Months**: XXX +129 **1 Year**: XXX -XX **1-Year High**: XXXXX on 2025-08-11 **1-Year Low**: X on 2025-02-09 ### Galaxy Score: XXXXX [#](/topic/$smmt/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/galaxy_score.tsv) **Current Value**: XXXXX **Daily Average**: XX **1 Week**: XX +4 **1 Month**: XX -X **6 Months**: XX -XX **1 Year**: XX +6 **1-Year High**: XX on 2025-04-22 **1-Year Low**: X on 2025-03-18 ### Engagements: XXXXX [#](/topic/$smmt/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXXXXX **1 Week**: XXXXXX -XX% **1 Month**: XXXXXXX -XX% **6 Months**: XXXXXXXXX +19% **1 Year**: XXXXXXXXX -XX% **1-Year High**: XXXXXXX on 2025-04-25 **1-Year Low**: XXX on 2025-09-20 | Social Network | Reddit | X | YouTube | | -------------- | ------ | - | ------- | | Engagements | XX | XXXXX | X | ### Mentions: XX [#](/topic/$smmt/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XXX **1 Month**: XXX -XX% **6 Months**: XXXXX -XXXX% **1 Year**: XXXXXX +62% **1-Year High**: XXX on 2025-07-18 **1-Year Low**: XX on 2025-10-07 | Social Network | Reddit | X | YouTube | | -------------- | ------ | - | ------- | | Mentions | X | XXX | X | ### Creators: XX [#](/topic/$smmt/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Summit Therapeutics Inc. Common Stock (SMMT) in the last XX hours which is up XX% from XX in the previous XX hours **Daily Average**: XXX **1 Month**: XXX -XX% **6 Months**: XXXXX +33% **1 Year**: XXXXX +108% **1-Year High**: XXX on 2025-07-18 **1-Year Low**: XX on 2025-10-07 The most influential creators that mention Summit Therapeutics Inc. Common Stock in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@Biotech2k1](/creator/twitter/Biotech2k1) | X | XXXXXX | X | XXXXX | | [@FL0WG0D](/creator/twitter/FL0WG0D) | X | XXXXXX | X | XXX | | [@EgrandeBilli](/creator/twitter/EgrandeBilli) | X | XXX | X | XXX | | [@Darensf1](/creator/twitter/Darensf1) | X | XXX | X | XXX | | [@OzmosiHealth](/creator/twitter/OzmosiHealth) | X | XXXXX | X | XX | | [@doepke_michel](/creator/twitter/doepke_michel) | X | XXXXX | X | XX | | [@stocket_rocket](/creator/twitter/stocket_rocket) | X | XXX | X | XX | | [@A1PHAEDGE](/creator/twitter/A1PHAEDGE) | X | XXX | X | XX | | [@BuyTheUgly](/creator/twitter/BuyTheUgly) | X | XX | X | XX | | [@FrenzyCapital](/creator/twitter/FrenzyCapital) | XX | XXXXX | X | XX | [View More](/list/creators/$smmt/100) ### Sentiment: XX% [#](/topic/$smmt/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% +53% **1 Month**: XX% +16% **6 Months**: XX% -XX% **1 Year**: XX% +6% **1-Year High**: XXX% on 2025-10-06 **1-Year Low**: XX% on 2025-03-23 **Most Supportive Themes** - **Upcoming Phase X Data:** (40%) The anticipation of upcoming Phase X data fuels investor excitement. - **Bullish Sentiment and Recognition:** (30%) Positive mentions and recognition of Summit Therapeutics as a potential long-term holding boost investor confidence. - **Strategic Partnerships:** (10%) Strategic collaborations, such as the ADC combo deal with Pfizer, are viewed positively by investors. **Most Critical Themes** - **Competition Intensification:** (3%) Investors are concerned about increased competition in the PD-1/VEGF bispecific antibody market. - **Conflicting Macroeconomic Signals:** (2%) Uncertainty is introduced by conflicting macroeconomic signals. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | Reddit | XX | X% | XX | X% | X | X% | | X | XXX | XX% | XXXXX | XX% | XX | X% | | YouTube | X | X% | X | X% | X | X% | | | | | | | | | | Total | XXX | XX% | XXXXX | XX% | XX | X% | ### Social Dominance: XXXXX% [#](/topic/$smmt/social_dominance) ---  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/social_dominance.tsv) **Current Value**: XXXXX% **Daily Average**: XXXXX% **1 Week**: XXXXX% +0.039% **1 Month**: XXXXX% -XXXXXXXXXXXXXXXXXXXXX% **6 Months**: XXXXX% -XXXXX% **1 Year**: XXXXX% -XXXX% **1-Year High**: XXXXX% on 2025-04-25 **1-Year Low**: XXXXXX% on 2025-10-07 ### Market Dominance: XXXXX% [#](/topic/$smmt/market_dominance) ---  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/market_dominance.tsv) **Current Value**: XXXXX% **Daily Average**: X% **1-Year High**: XXXXX% on 2025-03-31 **1-Year Low**: XXXXX% on 2025-09-10 ### Market Cap: $XXXXXXXXXXXXXX [#](/topic/$smmt/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/market_cap.tsv) **Current Value**: $XXXXXXXXXXXXXX **Daily Average**: $XXXXXXXXXXXXXX **1 Week**: $XXXXXXXXXXXXXX +$2.20% **1 Month**: $XXXXXXXXXXXXXX +$11% **6 Months**: $XXXXXXXXXXXXXX -$23% **1 Year**: $XXXXXXXXXXXXXX +$0.03% **1-Year High**: $XXXXXXXXXXXXXX on 2025-04-24 **1-Year Low**: $XXXXXXXXXXXXXX on 2025-04-08 **Top assets mentioned** In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours [Tesla, Inc. (TSLA)](/topic/tesla) [Dave Inc. Class A Common Stock (DAVE)](/topic/$dave) [Tesla, Inc. (TSLA)](/topic/$tsla) [Moonft (MTC)](/topic/$mtc) [Insmed, Inc. (INSM)](/topic/$insm) [One Cash (ONC)](/topic/$onc) [IonQ, Inc. (IONQ)](/topic/$ionq) [NVIDIA Corp. (NVDA)](/topic/$nvda) [AstraZeneca PLC (AZN)](/topic/$azn) **Top topics mentioned** In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks healthcare](/topic/stocks-healthcare), [stocks technology](/topic/stocks-technology), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [coins made in usa](/topic/coins-made-in-usa), [$gsun](/topic/$gsun), [tesla](/topic/tesla), [$9926hk](/topic/$9926hk), [discord](/topic/discord), [$dave](/topic/$dave), [stocks industrials](/topic/stocks-industrials), [$tsla](/topic/$tsla), [$dsa](/topic/$dsa), [stocks basic materials](/topic/stocks-basic-materials), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$mtc](/topic/$mtc), [stocks](/topic/stocks), [china](/topic/china), [$bntx](/topic/$bntx), [$insm](/topic/$insm), [$onc](/topic/$onc), [stocks financial services](/topic/stocks-financial-services), [$cmnd](/topic/$cmnd), [$ionq](/topic/$ionq), [$nvda](/topic/$nvda), [$azn](/topic/$azn), [$pfe](/topic/$pfe), [coins defi](/topic/coins-defi), [advanced micro devices](/topic/advanced-micro-devices), [stocks consumer defensive](/topic/stocks-consumer-defensive), [stocks communication services](/topic/stocks-communication-services), [$rytm](/topic/$rytm), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$orcl](/topic/$orcl), [$crwv](/topic/$crwv), [$incy](/topic/$incy), [united therapeutics corp](/topic/united-therapeutics-corp), [$uthr](/topic/$uthr), [$exel](/topic/$exel), [quarterly earnings](/topic/quarterly-earnings), [$anet](/topic/$anet), [$rapp](/topic/$rapp), [$bmy](/topic/$bmy), [gilead sciences](/topic/gilead-sciences), [$gild](/topic/$gild), [$til](/topic/$til), [coins layer 1](/topic/coins-layer-1), [$mrna](/topic/$mrna), [$nok](/topic/$nok), [coins base ecosystem](/topic/coins-base-ecosystem), [trading strategy](/topic/trading-strategy), [stocks real estate](/topic/stocks-real-estate), [$mdlz](/topic/$mdlz), [$intc](/topic/$intc), [stocks bitcoin miners](/topic/stocks-bitcoin-miners), [$run](/topic/$run), [coins lending borrowing](/topic/coins-lending-borrowing), [$abbv](/topic/$abbv), [$mos](/topic/$mos), [$teck](/topic/$teck), [baker](/topic/baker), [$akesf](/topic/$akesf), [$mdgl](/topic/$mdgl), [united states](/topic/united-states), [$rvmd](/topic/$rvmd), [$rna](/topic/$rna), [$dnth](/topic/$dnth), [$idya](/topic/$idya), [$kura](/topic/$kura), [$eose](/topic/$eose), [$clf](/topic/$clf), [$dx](/topic/$dx), [$hbt](/topic/$hbt), [$vtgnpremarket](/topic/$vtgnpremarket), [dd](/topic/dd), [money](/topic/money), [$rbrk](/topic/$rbrk), [$hdb](/topic/$hdb), [$bma](/topic/$bma), [$ypf](/topic/$ypf), [$irdm](/topic/$irdm), [$slde](/topic/$slde), [morgan stanley](/topic/morgan-stanley), [morgan](/topic/morgan), [flood](/topic/flood), [cracks](/topic/cracks), [$agio](/topic/$agio), [$bbio](/topic/$bbio), [$bmrn](/topic/$bmrn), [$alks](/topic/$alks), [$316k](/topic/$316k), [coins arbitrum](/topic/coins-arbitrum), [$prva](/topic/$prva), [$amd](/topic/$amd), [$nflx](/topic/$nflx), [stocks banks](/topic/stocks-banks), [ibm](/topic/ibm), [wall street](/topic/wall-street), [upside](/topic/upside), [$sdgr](/topic/$sdgr) ### Top Social Posts [#](/topic/$smmt/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$SMMT Strong Partnerships Ahead πππ The companys collaboration with Akeso in China gives it exclusive North America rights creating future licensing and milestone potential. πOnly insiders get alerts join before it spikes π" [X Link](https://x.com/EgrandeBilli/status/1979731346017882385) [@EgrandeBilli](/creator/x/EgrandeBilli) 2025-10-19T02:08Z XXX followers, XX engagements "$SMMT Global Collaboration Strengthπππ Summits alliance with Akeso Biopharma accelerates global development of ivonescimab combining innovation and commercial scale. πOnly insiders get alerts join before it spikes π" [X Link](https://x.com/EgrandeBilli/status/1979608865152159818) [@EgrandeBilli](/creator/x/EgrandeBilli) 2025-10-18T18:01Z XXX followers, XXX engagements "$UTHR/$EXEL/$MDGL/$SMMT: Four commercial-stage biotechs liked but not owned fully valued today buyable on a real sell-off. Smart money watches catalysts (readouts approvals) cash runway and valuation multiples not PR soundbites. Size like a PM buy the reset not the hype" [X Link](https://x.com/lintrix_x/status/1979608415661064227) [@lintrix_x](/creator/x/lintrix_x) 2025-10-18T18:00Z 2884 followers, XX engagements "I got X commercial stage biotech names that I do like but I do not own right now. I would if biotech ever sold off and they got cheap again but I think they are all fully valued right now. They are $UTHR $EXEL $MDGL and $SMMT" [X Link](https://x.com/Biotech2k1/status/1979585374755164454) [@Biotech2k1](/creator/x/Biotech2k1) 2025-10-18T16:28Z 32.4K followers, 4400 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Summit Therapeutics shares are up amid reports of a potential $15B licensing deal with AstraZeneca. Ivonescimab data disappoints in Western patients, causing concern.
Summit Therapeutics Inc. Common Stock (SMMT) is a biopharmaceutical company.
Summit Therapeutics Inc. Common Stock uses the ticker $SMMT for trading. Listed in the Stocks and category.
Price 24-Hour Time-Series Raw Data
The XXXX% price increase appears to be driven by positive market sentiment, hype from top creators, the anticipation of Phase X data, and a potential deal with AstraZeneca, fueled by rumors of a $XX billion partnership and increased social engagement.
24-Hour | 7-Day | 30-Day |
---|---|---|
-XXXX% | -XXXX% | XXXXX% |
1-Year High: $XXXXX on 2025-04-24
1-Year Low: $XXXXX on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
Summit Therapeutics Inc. Common Stock (SMMT) is currently AltRank #196 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX +535
1 Month: XXX -XXX
6 Months: XXX +129
1 Year: XXX -XX
1-Year High: XXXXX on 2025-08-11
1-Year Low: X on 2025-02-09
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +4
1 Month: XX -X
6 Months: XX -XX
1 Year: XX +6
1-Year High: XX on 2025-04-22
1-Year Low: X on 2025-03-18
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +19%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-04-25
1-Year Low: XXX on 2025-09-20
Social Network | X | YouTube | |
---|---|---|---|
Engagements | XX | XXXXX | X |
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX -XXXX%
1 Year: XXXXXX +62%
1-Year High: XXX on 2025-07-18
1-Year Low: XX on 2025-10-07
Social Network | X | YouTube | |
---|---|---|---|
Mentions | X | XXX | X |
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Summit Therapeutics Inc. Common Stock (SMMT) in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX +33%
1 Year: XXXXX +108%
1-Year High: XXX on 2025-07-18
1-Year Low: XX on 2025-10-07
The most influential creators that mention Summit Therapeutics Inc. Common Stock in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@Biotech2k1 | X | XXXXXX | X | XXXXX |
@FL0WG0D | X | XXXXXX | X | XXX |
@EgrandeBilli | X | XXX | X | XXX |
@Darensf1 | X | XXX | X | XXX |
@OzmosiHealth | X | XXXXX | X | XX |
@doepke_michel | X | XXXXX | X | XX |
@stocket_rocket | X | XXX | X | XX |
@A1PHAEDGE | X | XXX | X | XX |
@BuyTheUgly | X | XX | X | XX |
@FrenzyCapital | XX | XXXXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +53%
1 Month: XX% +16%
6 Months: XX% -XX%
1 Year: XX% +6%
1-Year High: XXX% on 2025-10-06
1-Year Low: XX% on 2025-03-23
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
XX | X% | XX | X% | X | X% | |
X | XXX | XX% | XXXXX | XX% | XX | X% |
YouTube | X | X% | X | X% | X | X% |
Total | XXX | XX% | XXXXX | XX% | XX | X% |
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.039%
1 Month: XXXXX% -XXXXXXXXXXXXXXXXXXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXX%
1-Year High: XXXXX% on 2025-04-25
1-Year Low: XXXXXX% on 2025-10-07
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXX% on 2025-09-10
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXX +$2.20%
1 Month: $XXXXXXXXXXXXXX +$11%
6 Months: $XXXXXXXXXXXXXX -$23%
1 Year: $XXXXXXXXXXXXXX +$0.03%
1-Year High: $XXXXXXXXXXXXXX on 2025-04-24
1-Year Low: $XXXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours
Tesla, Inc. (TSLA) Dave Inc. Class A Common Stock (DAVE) Tesla, Inc. (TSLA) Moonft (MTC) Insmed, Inc. (INSM) One Cash (ONC) IonQ, Inc. (IONQ) NVIDIA Corp. (NVDA) AstraZeneca PLC (AZN)
Top topics mentioned In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours
stocks consumer cyclical, stocks healthcare, stocks technology, stocks bitcoin treasuries, coins made in usa, $gsun, tesla, $9926hk, discord, $dave, stocks industrials, $tsla, $dsa, stocks basic materials, coins solana ecosystem, $mtc, stocks, china, $bntx, $insm, $onc, stocks financial services, $cmnd, $ionq, $nvda, $azn, $pfe, coins defi, advanced micro devices, stocks consumer defensive, stocks communication services, $rytm, stocks crypto treasuries, $orcl, $crwv, $incy, united therapeutics corp, $uthr, $exel, quarterly earnings, $anet, $rapp, $bmy, gilead sciences, $gild, $til, coins layer 1, $mrna, $nok, coins base ecosystem, trading strategy, stocks real estate, $mdlz, $intc, stocks bitcoin miners, $run, coins lending borrowing, $abbv, $mos, $teck, baker, $akesf, $mdgl, united states, $rvmd, $rna, $dnth, $idya, $kura, $eose, $clf, $dx, $hbt, $vtgnpremarket, dd, money, $rbrk, $hdb, $bma, $ypf, $irdm, $slde, morgan stanley, morgan, flood, cracks, $agio, $bbio, $bmrn, $alks, $316k, coins arbitrum, $prva, $amd, $nflx, stocks banks, ibm, wall street, upside, $sdgr
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$SMMT Strong Partnerships Ahead πππ The companys collaboration with Akeso in China gives it exclusive North America rights creating future licensing and milestone potential. πOnly insiders get alerts join before it spikes π"
X Link @EgrandeBilli 2025-10-19T02:08Z XXX followers, XX engagements
"$SMMT Global Collaboration Strengthπππ Summits alliance with Akeso Biopharma accelerates global development of ivonescimab combining innovation and commercial scale. πOnly insiders get alerts join before it spikes π"
X Link @EgrandeBilli 2025-10-18T18:01Z XXX followers, XXX engagements
"$UTHR/$EXEL/$MDGL/$SMMT: Four commercial-stage biotechs liked but not owned fully valued today buyable on a real sell-off. Smart money watches catalysts (readouts approvals) cash runway and valuation multiples not PR soundbites. Size like a PM buy the reset not the hype"
X Link @lintrix_x 2025-10-18T18:00Z 2884 followers, XX engagements
"I got X commercial stage biotech names that I do like but I do not own right now. I would if biotech ever sold off and they got cheap again but I think they are all fully valued right now. They are $UTHR $EXEL $MDGL and $SMMT"
X Link @Biotech2k1 2025-10-18T16:28Z 32.4K followers, 4400 engagements
/topic/$smmt